EGFR-mutated non-small cell lung cancer Post date 5 June 2025 ← The US executive order establishing “Gold Standard Science” does anything but → Sacituzumab tirumotecan versus docetaxel for previously treated EGFR-mutated advanced non-small cell lung cancer